title: Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
authors.affiliation: Ophthalmology Department, DHU SightRestore, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Diem-Trang
authors.initials: DT
authors.lastname: Nguyen
authors.affiliation: APHP, Sorbonne Universités, Department of Neurology, Paris, France; LOC Network, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Caroline
authors.initials: C
authors.lastname: Houillier
authors.affiliation: Clinical Hematology Department, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Sylvain
authors.initials: S
authors.lastname: Choquet
authors.affiliation: Ophthalmologic Oncology Department, Institut Curie, Paris, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Cassoux
authors.affiliation: Haematology Department, Institut René Huguenin, Saint Cloud, France.
authors.forename: Carole
authors.initials: C
authors.lastname: Soussain
authors.affiliation: Biostatistics, Medical Informatic Department, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Chloé
authors.initials: C
authors.lastname: Le Cossec
authors.affiliation: Biological Hematology Department, Pitie Salpetriere Hospital, Paris, France; University Pierre et Marie Curie, Paris, France.
authors.forename: Magali
authors.initials: M
authors.lastname: Legarf-Tavernier
authors.affiliation: Biological Hematology Department, Pitie Salpetriere Hospital, Paris, France; University Pierre et Marie Curie, Paris, France.
authors.forename: Myrto
authors.initials: M
authors.lastname: Costopoulos
authors.affiliation: Ophthalmology Department, DHU SightRestore, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Phuc
authors.initials: P
authors.lastname: LeHoang
authors.affiliation: Ophthalmology Department, DHU SightRestore, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Bahram
authors.initials: B
authors.lastname: Bodaghi
authors.affiliation: APHP, Sorbonne Universités, Department of Neurology, Paris, France; LOC Network, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Antonio
authors.initials: A
authors.lastname: Omuro
authors.affiliation: APHP, Sorbonne Universités, Department of Neurology, Paris, France; LOC Network, Pitie-Salpetriere Hospital, Paris, France.
authors.forename: Khe
authors.initials: K
authors.lastname: Hoang-Xuan
authors.affiliation: Ophthalmology Department, DHU SightRestore, Pitie-Salpetriere Hospital, Paris, France. Electronic address: valerie.touitou@aphp.fr.
authors.forename: Valérie
authors.initials: V
authors.lastname: Touitou
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002531:Cerebellum / Q000000981:diagnostic imaging; D003561:Cytarabine / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005134:Eye Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011344:Procarbazine / Q000008:administration & dosage; D016019:Survival Analysis; D000077204:Temozolomide; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D011344:Procarbazine; D014750:Vincristine; D003606:Dacarbazine; D000077204:Temozolomide; D008727:Methotrexate